Open Email...Your Power Lunch Trades Ideads Inside…
| | | | | | | Dear Reader, | | I hope you are having a great Wednesday! I am sending you the list of options signals for the next trading day (to help you cut your research in finding trading and/or investing opportunities). | Low-float biotech with a bold $500M funding move + breakthrough immune-oncology tech. (ad)*
A move that could attract both biotech investors and an entirely new class of capital. With human trials planned and a float so small it can move fast on headlines, this setup has all the hallmarks of a biotech story that can change quickly.
See why some investors are circling now before the next update hits the tape. | | Stock Name | Signal Date | Signal Name |
|---|
| COST | Aug 20 | Golden Crossover | | BX | Aug 20 | Golden Crossover | | N0W | Aug 20 | Golden Crossover | | BHP | Aug 20 | Golden Crossover | | QCOM | Aug 20 | Below 200-MA | | ARM | Aug 20 | Below 200-MA | | PANW | Aug 20 | Below 200-MA | | STRC | Aug 20 | Below 200-MA | | NTES | Aug 20 | Double Top | | GRMN | Aug 20 | Double Top | | CNP | Aug 20 | Double Top | | FOX | Aug 20 | Double Top | | CRM | Aug 20 | Double Bottom | | ADBE | Aug 20 | Double Bottom | | BMY | Aug 20 | Double Bottom | | INFY | Aug 20 | Double Bottom | | Click Here to View Your Full Report |
| | | | | 🚨 Elon's BIGGEST warning yet? (ad)
Tesla's About to Prove Everyone Wrong... Again 🗓️ On October 23rd, Tesla is set to unveil a groundbreaking AI breakthrough, dubbed "Manifested AI," that could create a 25,000% growth market overnight. However, the best investment opportunity lies not with Tesla but with a lesser-known stock, 168 times SMALLER than Nvidia, poised to capitalize on this explosive market.
👉 Click here to see your "second chance" opportunity… | | How to use signals in your trading/investing strategies: | | Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's trade signal) or the Price Reversal strategy (to target the reversal following signal generation). Please click on Ride-the-Wave Strategy to learn more about it. | | Stock Trading - If you're a swing stock trader/investor or portfolio manager, you may want to consider entering or exiting your positiosn based on a the signal generation. Please click on Volatility Crush Strategy to learn more about it. | Safer cancer therapy + $500M funding twist. Low float setup traders are watching closely. (ad)*
Two billion-dollar markets. Multiple near-term catalysts. A history of moving sharply on news. It's the kind of rare setup that doesn't linger unnoticed for long. See why the clock may already be ticking.
Get the full breakdown and symbol here. | | At Options Hero, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. | | To your trading success, | | Support Team | | Options Hero | | PS:Options Hero is morning newsletter, powered by StockEarnings proprietary technology. | | | | | | |
| | | (ad)* This message is a PAID ADVERTISEMENT for Liminatus Pharma Inc (NASDAQ:LIMN) from Market Jar Media Inc. StockEarnings, Inc. has received a fixed fee of $25000 from Market Jar Media Inc for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between August 14, 2025 and August 21, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Liminatus Pharma Inc (NASDAQ:LIMN) or Market Jar Media Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Liminatus Pharma Inc (NASDAQ:LIMN) on TradingWhisperer website for additional information about the relationship between Market Jar Media Inc and Liminatus Pharma Inc (NASDAQ:LIMN). Options Hero is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS | Unsubscribe
Today's Bonus Content: The Cancer Breakthrough With a Rare Funding Play (ad)*
| | |
